Traditional Chinese medicine prescription for treating iridocyclitis

Abstract

The invention relates to a traditional Chinese medicine prescription for treating iridocyclitis. The traditional Chinese medicine prescription is prepared from the following active pharmaceutical ingredients: 12g of areca seed, 30g of feather cockscomb seed, 9g of oriental waterplantain rhizome, 12g of simpleleaf shrub chastetree fruit, 12g of motherwort fruit, 12g of motherwort fruit, 12g of Chinese gentian, 12g of tabasheer and 9g of common lophatherum herb, wherein in the case of sore red eyes, 12g of tree peony bark, 9g of rehmannia root, 12g of baical skullcap root and 9g of dahurian angelica root can be added to the active pharmaceutical ingredients to remove redness and stop soreness; in the case of thirst, constipation and hypopyon, 12g of gypsum, 12g of common anemarrhena rhizome and 9g of rhubarb can be selectively added to the active pharmaceutical ingredients to purge the fire of yangming meridians; for people with severer rheumatism, stuffy gastral cavities and greasy furs, 12g of officinal magnolia bark and 9g of fructus amomi rotundus can be selectively added to the active pharmaceutical ingredients to regulate qi by alleviation of mental depression and remove dampness. One dose of the traditional Chinese medicine prescription is taken a day after the traditional Chinese medicine prescription is decocted in water and one course of treatment lasts 15 days. The traditional Chinese medicine prescription is reasonable in compatibility, has direct effects, short course of treatment and small toxic and side effects and takes effect quickly.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine prescription for treating iridocyclitis. Background technique [0002] Iridocyclitis, referred to as iridocyclitis, also known as anterior uveitis, is a type of iridocyclitis caused by a variety of reasons, mostly occurs in young adults, often recurrent. Patients may experience eye pain, photophobia, tearing, and blurred vision. When there is a large amount of fibrin exudation in the anterior chamber or reactive macula and papilledema, it can cause significant loss of vision, concurrent cataracts, and secondary glaucoma can lead to severe loss of vision. The current treatment method is based on the principle of rapidly eliminating inflammation and preventing posterior synechia of the iris. The current treatment method is 2% homatropine eye ointment, twice a day, and 1% atropine sulfate eye ointment can also be used first, and ...

AI Technical Summary

Problems solved by technology

The current treatment method is 2% homatropine eye ointment, twice a day, or 1% atropine sulfate eye ointment first, and then change to 2% homatropine eye ointment after 1-2 days. Certain therapeutic effect, but the course of treatment is long and easy to relapse